We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advances Pharmacogenomics With Final Guidance on Submissions
FDA Advances Pharmacogenomics With Final Guidance on Submissions
March 22, 2005
The FDA is encouraging drugmakers to voluntarily submit pharmacogenomic data as part of an initiative to speed the development of personalized therapies based on patients’ genetic profiles, according to a new final guidance.